A carregar...
The pivotal role of mammalian target of rapamycin inhibition in the treatment of patients with neuroendocrine tumors
Significant advances have been made toward understanding the biology of neuroendocrine tumors (NET) in terms of defining prognosis and improving clinical management; however, many unmet needs remain. The treatment landscape for NET has evolved, with the approval of the targeted agents everolimus and...
Na minha lista:
| Publicado no: | Cancer Med |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5083749/ https://ncbi.nlm.nih.gov/pubmed/27539383 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.742 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|